期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 260, 期 -, 页码 -出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2023.115776
关键词
HDAC6 inhibitor; TH beta C; Selectivity; Antiproliferative; Synthesis
In this study, a series of novel selective HDAC6 inhibitors were designed and synthesized, showing good anti-proliferative activity against multiple tumor cell lines and high selectivity.
A series of tetrahydro-beta-carboline (TH beta C)-based hydroxamic acids were rationally designed and synthesized as novel selective HDAC6 inhibitors (sHDAC6is) by the application of scaffold hopping strategy. Several TH beta C analogues were highly potent (IC50 < 5 nM) and selective against HDAC6 enzyme and exhibited good anti proliferative activity against human multiple myeloma (MM) cell. Molecular docking interpreted the structure activity relationship (SAR). Target engagement of HDAC6 was confirmed in RPMI-8226 cells using the WB assay. In vitro, (1S, 3R)-1-(4-chlorophenyl)-N-(4-(hydroxycarbamoyl)benzyl)-2,3,4,9-tetrahydro-1H-pyrido[3, 4-b] indole-3-carboxamide (14g) showed potent broad antiproliferative activity against various tumors including leukemia, colon cancer, melanoma, and breast cancer cell lines, better than ACY-1215. Moreover, 14g also showed good pharmacokinetics properties in mice via oral administration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据